Pediatric Rheumatology Highlights

• Abstract 632: Predictors of Bone Mineral Density (BMD) in a Large Cohort of Children with Juvenile Idiopathic Arthritis
• Abstract: 222: Alendronate Treatment of Pediatric Patients with Connective Tissues Disorders. A Ten Year Follow-Up Study
• Abstract: 1282: Preliminary Evidence for Sustained Bioactivity of IL-1 Trap (Rilonacept), A Long Acting IL-1 Inhibitor, In Systemic Juvenile Idiopathic Arthritis (SJIA)
• Abstract: 682: Safety and Efficacy of Over 8 Years of Continuous Etanercept (Enbrel®) Therapy in Patients With Juvenile Rheumatoid Arthritis
• Abstract: 681: Adalimumab is Safe and Effective During Long-Term Treatment of Patients with Juvenile Rheumatoid Arthritis: Results from a 2-Year Study
• Abstract 679: Efficacy of Abatacept in Different Sub-Populations of Juvenile Idiopathic Arthritis (JIA): Results of a Randomized Withdrawal Study
• Abstract: 680: Abatacept Treatment of Juvenile Idiopathic Arthritis (JIA): Safety Report